Apellis Pharmaceuticals Stock Price on July 22, 2025
| APLS Stock | USD 24.26 1.31 5.71% |
If you're considering investing in Apellis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Apellis Pharmaceuticals stands at 24.26, as last reported on the 5th of August, with the highest price reaching 24.32 and the lowest price hitting 22.89 during the day. Apellis Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Apellis Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14 % return per unit of standard deviation over the last 3 months. By analyzing Apellis Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please makes use of Apellis Pharmaceuticals' risk adjusted performance of 0.0924, and Mean Deviation of 2.8 to double-check if our risk estimates are consistent with your expectations. At this time, Apellis Pharmaceuticals' Common Stock Total Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 3.4 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 64 M in 2025. . Price To Sales Ratio is likely to drop to 4.81 in 2025. Price Earnings Ratio is likely to gain to -18.98 in 2025. Apellis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Price Book 18.5429 | Enterprise Value Ebitda (12.12) | Price Sales 3.8407 | Shares Float 78.1 M | Wall Street Target Price 36.9 |
Related Headline
Blueprint Medicines Headline on 17th of July 2025
Blueprint Medicines Reaches New 52-Week High Heres Why by thelincolnianonline.com
Blueprint Medicines Corporation s stock price hit a new 52-week high on Wednesday . The company traded as high as 129.65 and last traded at 129.28, with a volume of 25678550 shares traded. The stock had previously closed at 129.35. Analyst Upgrades and Downgrades A number of equities analysts have weighed
Apellis Pharmaceuticals Valuation on July 22, 2025
It is possible to determine the worth of Apellis Pharmaceuticals on a given historical date. On July 22, 2025 Apellis was worth 19.32 at the beginning of the trading date compared to the closed value of 19.89. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Apellis Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Apellis Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Apellis Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Apellis Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 19.76 | 20.02 | 19.21 | 19.28 | 1,615,174 | |
07/22/2025 | 19.32 | 20.09 | 19.09 | 19.89 | 1,884,043 |
| 20.18 | 20.40 | 19.75 | 19.90 | 2,440,972 |
| Backtest Apellis Pharmaceuticals | | | Apellis Pharmaceuticals History | | | Apellis Pharmaceuticals Valuation | Previous | Next |
Apellis Pharmaceuticals Trading Date Momentum on July 22, 2025
| On July 23 2025 Apellis Pharmaceuticals was traded for 19.90 at the closing time. The top price for the day was 20.40 and the lowest listed price was 19.75 . The trading volume for the day was 2.4 M. The trading history from July 23, 2025 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 0.05% . The overall trading delta against the current closing price is 11.92% . |
Apellis Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Apellis Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Apellis Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Apellis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Apellis Pharmaceuticals Stock history
Apellis Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Apellis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Apellis Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Apellis Pharmaceuticals stock prices may prove useful in developing a viable investing in Apellis Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 123.9 M | 64 M | |
| Net Loss | -587 M | -557.6 M |
Apellis Pharmaceuticals Quarterly Net Working Capital |
|
Apellis Pharmaceuticals Stock Technical Analysis
Apellis Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Apellis Pharmaceuticals Period Price Range
Low | August 5, 2025
| High |
0.00 | 0.00 |
Apellis Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Apellis Pharmaceuticals August 5, 2025 Market Strength
Market strength indicators help investors to evaluate how Apellis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Apellis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Apellis Pharmaceuticals stock market strength indicators, traders can identify Apellis Pharmaceuticals entry and exit signals to maximize returns
Apellis Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Apellis Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Apellis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Apellis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0924 | |||
| Jensen Alpha | 0.349 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.1091 | |||
| Treynor Ratio | 0.646 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Apellis Stock Analysis
When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.